|
HS Code |
266557 |
| Chemical Formula | C11H16BNO3 |
| Molecular Weight | 221.06 |
| Appearance | Solid (predicted) |
| Boiling Point | N/A (no data found) |
| Melting Point | N/A (no data found) |
| Solubility | Soluble in organic solvents (predicted) |
| Pka | N/A (no data found) |
| Logp | N/A (no data found) |
| Flash Point | N/A (no data found) |
| Density | N/A (no data found) |
As an accredited 2-Borono-1H-Pyrrole-1-Carboxylic Acid 1-(1,1-Dimethylethyl) Ester factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 100g of 2 - Borono - 1H - Pyrrole - 1 - Carboxylic Acid 1 - (1,1 - Dimethylethyl) Ester in sealed vial. |
| Shipping | 2 - Borono - 1H - pyrrole - 1 - carboxylic acid 1 - (1,1 - dimethylethyl) ester is shipped in properly sealed, corrosion - resistant containers. Special care is taken to ensure compliance with chemical shipping regulations to prevent leakage during transit. |
| Storage | 2 - Borono - 1H - Pyrrole - 1 - Carboxylic Acid 1 - (1,1 - Dimethylethyl) Ester should be stored in a cool, dry place away from heat sources and direct sunlight. Keep it in a tightly sealed container to prevent moisture absorption and exposure to air, which could lead to degradation. Store it separately from incompatible substances to avoid potential chemical reactions. |
In the synthesis of ATP-competitive kinase inhibitors containing a 2-aryl-1H-pyrrole pharmacophore – such as certain sunitinib analogues and JAK2-targeted candidates – the heteroaryl Suzuki coupling of N-Boc-2-pyrroleboronic acid with electron-deficient aryl bromides constitutes the key step for C–C bond construction under cGMP (ICH Q7, 21 CFR Part 211) commercial production. The boron reagent is typically charged at 1.20–1.35 equivalents relative to the aryl halide to compensate for limited protodeboronation observed when the reaction mass is held above 75 °C for more than 6 hours in a THF/water biphasic system. Process validation data from pilot campaigns using a 500 L glass-lined reactor indicate that a catalyst loading of Pd(dppf)Cl₂·CH₂Cl₂ at 0.5 mol% with K₃PO₄ (2.0 equiv) at 65–70 °C reliably achieves >98% conversion within 4 h, after which the reaction is quenched with an aqueous 5 wt% N-acetylcysteine solution at 45 °C to scavenge palladium species. The isolated intermediate – a tert-butoxycarbonyl-protected 2-arylpyrrole – is crystallised from n-heptane/ethyl acetate (4:1 v/v) to a purity exceeding 99.5 % (HPLC, λ=254 nm), with residual palladium consistently below 10 ppm as determined by ICP-MS per USP ⟨233⟩. Downstream, the Boc group is cleaved with anhydrous HCl in 2-propanol (4 M, 20–25 °C, 2 h) in a polytetrafluoroethylene-lined vessel to avoid stainless-steel corrosion; after neutralisation with aqueous NaHCO₃ and solvent swap to methanol, the free pyrrole intermediate is telescoped into the final sulfonamide coupling. The terminal finished product is a 2,5-disubstituted pyrrole active pharmaceutical ingredient, formulated as the monohydrochloride salt in oral tablets of 25 mg and 100 mg strength, where the manufacturing process is validated for an annual throughput of approximately 15–20 metric tonnes of the key intermediate.
Residual Palladium Speciation in Agrochemical Intermediates and Its Impact on OECD 209-Compliant Ecotoxicity StudiesWhen the same N-Boc-2-pyrroleboronic acid ester is deployed in the manufacture of herbicidal active ingredients – for example pyrrole-2-carboxamide inhibitors of protoporphyrinogen oxidase (PPO) – regulatory authorities in OECD member countries demand exhaustive ecotoxicological profiling according to OECD Test Guideline 209 (Activated Sludge, Respiration Inhibition Test) and EPA 40 CFR Part 158 Tier II data. The palladium burden from the Suzuki coupling must therefore be reduced to a threshold of < 5 ppm total Pd in the technical-grade active ingredient, because palladium(II) ions at 1–2 mg/L have been shown to suppress heterotrophic respiration in sewage treatment plant inocula by more than 50 %. The coupling is performed with the boronate ester dosed at 1.05–1.15 equivalents relative to a 2-iodo-4-chlorobenzene derivative, using Pd(OAc)₂ (0.2 mol%) and PPh₃ (0.6 mol%) in a degassed toluene/ethanol/water mixture at 78 °C under nitrogen. Following phase separation, the organic layer is treated with a metal scavenger resin (thiourea-functionalised polystyrene, 2 wt% loading) for 12 h at 50 °C, followed by filtration through a 0.5 µm polypropylene depth filter. The Boc-protected intermediate is then subjected to acetic acid-catalysed deprotection at 55 °C in a 3:1 v/v THF/water mixture to avoid the use of strong mineral acids that would compromise downstream wastewater treatability. After neutralisation and crystallisation from cyclohexane, the free pyrrole carboxylic acid intermediate is coupled with an amine arm in dimethylformamide using EDC·HCl and HOBt, yielding the pro-herbicide ethyl ester. The final product, a substituted 3-chloro-4-(1H-pyrrol-2-yl)benzamide, is formulated as a 50 g/L emulsifiable concentrate meeting FAO specification AGP:CP/2097 and registered under EU PPP Regulation EC 1107/2009. The direct incorporation of N-Boc-2-pyrroleboronic acid ester as a functional comonomer in glucose-responsive hydrogels necessitates precise control over deprotection kinetics to prevent hydrogel network collapse during the acidic cleavage step. For a subcutaneous continuous glucose monitoring sensor membrane, the copolymerisation is carried out using 2-hydroxyethyl methacrylate (HEMA, 94.5 mol%), acrylamide (4.0 mol%), and the boronic ester monomer (1.2 mol%) along with tetraethylene glycol dimethacrylate (TEGDMA, 0.3 mol%) as crosslinker, initiated by Irgacure 2959 photoinitiator (0.1 wt%) under 365 nm UV radiation at 50 mW/cm² for 45 minutes in a nitrogen-purged glove box. After polymerisation, the hydrogel discs are swollen in dichloromethane and treated with trifluoroacetic acid/triisopropylsilane (95:5 v/v) at 0 °C for 3 h to remove the Boc group while preserving glucosidic stimuli-responsiveness, then equilibrated in phosphate-buffered saline (pH 7.4) to an equilibrium water content of 68–72 wt%. Biocompatibility is evaluated per ISO 10993-5 (MEM elution test, clause 8.2) and intracutaneous reactivity ISO 10993-10; the membrane demonstrates > 90% cell viability at 48 h and a glucose binding constant of 13 ± 2 M⁻¹ as determined by equilibrium dialysis. The manufacturing process is carried out on a Class 7 cleanroom bench, with in-process microbial bioburden controlled to < 10 CFU/g prior to sterilisation by 25 kGy electron beam irradiation. The terminal device assembly – a 0.2 mm thick, 6 mm diameter boronic acid-functionalised hydrogel disc integrated with an optical glucose transducer – constitutes a component of an implantable continuous glucose monitor, regulated as a Class IIb medical device under EU MDR 2017/745 and FDA 21 CFR 862.1355. Carrier Mobility in Poly(3-alkylthiophene-co-N-Boc-pyrrole) Copolymers: A Monomer Purity Threshold StudyIn the field of organic field-effect transistors (OFETs), a series of donor–acceptor copolymers synthesised via Stille copolymerisation of 2-bromo-3-hexylthiophene and N-Boc-2-(tributylstannyl)pyrrole – derived from the corresponding boronic ester through palladium-catalysed stannylation – have been interrogated for hole-transport properties. Carrier mobility measured in bottom-gate, top-contact devices fabricated on octadecyltrichlorosilane-treated SiO₂ (300 nm dielectric) reveals a drastic decline from 0.35 cm²/V·s to 0.05 cm²/V·s when the cumulative iron content in the boronic ester monomer exceeds 50 ppb, as quantified by GF-AAS; thus the monomer specification for electronic-grade material is set at ≥ 99.95 % purity with individual metal impurities (Fe, Ni, Cu) below 25 ppb, compliant with SEMI C33-0212 and DIN 50450-3 test methods. The copolymerisation is conducted with a molar feed ratio of thiophene to pyrrole of 1 : 0.30, using Pd₂(dba)₃ (1.5 mol%) and tri(o-tolyl)phosphine (6 mol%) in anhydrous chlorobenzene at 130 °C for 72 h under argon. The crude polymer is precipitated into methanol, purified by sequential Soxhlet extraction with acetone and hexane, and finally fractionated by preparative GPC in 1,2-dichlorobenzene at 70 °C to obtain a number-average molecular weight (Mn) of 45 000 g/mol with a dispersity < 1.4. Thin films (40 nm) are spin-coated from 5 mg/mL 1,2-dichlorobenzene solutions at 2000 rpm and annealed at 180 °C for 15 min under nitrogen. The terminal OFET device incorporating this copolymer as the semiconductor layer exhibits an on/off current ratio of > 10⁶ and a threshold voltage of −8 V, suitable for driving flexible e-paper backplanes manufactured under IPC-6013 cleanroom assembly standards. The final commercial product is a flexible active-matrix electrophoretic display with a resolution of 300 dpi. What Limits the Specific Activity of 18F-Labeled Boronic Ester PET Tracers in Preclinical Imaging?Radiochemical yields of 18F-labeled N-Boc-2-(4-fluorophenyl)pyrrole tracers produced via copper-mediated radiofluorination of the corresponding pinacol boronic ester – which is prepared by ligand exchange from the tert-butyl ester – are critically dependent on the absolute dryness of the azeotropically dried [18F]fluoride/K2.2.2/K₂CO₃ complex and the exclusion of protic solvents during the labelling step. In a typical cassette-based synthesis on a Synthra RNplus module, the Boc-protected aryl pyrrole boronate (10 µmol, 6 mg/mL in anhydrous N,N-dimethylacetamide) is reacted with [18F]fluoride in the presence of Cu(OTf)₂ (4 µmol) and pyridine (40 µmol) at 110 °C for 20 min, after which the reaction is quenched with 1 mL of water and semipreparative HPLC purification is performed on a C18 column (250 × 10 mm, 5 µm) using 45:55 v/v acetonitrile/water at 4 mL/min. Isolation of the Boc-protected intermediate prior to acid-catalysed deprotection is avoided, because partial thermal decarboxylation under the radiofluorination conditions generates < 2% of the unprotected pyrrole impurity that co-elutes with the product; instead, the collected fraction is concentrated and treated with 0.5 M HCl at 100 °C for 5 min to simultaneously remove the Boc group and effect cation release. The final 18F-labelled 2-(4-fluorophenyl)pyrrole tracer is formulated in 10 mL of 0.9 % sodium chloride containing < 5% ethanol and sterilising-filtered through a 0.22 µm PVDF membrane, yielding a radiochemical purity of > 99 % and a specific activity of 120–250 GBq/µmol at end of synthesis. The entire procedure complies with USP ⟨823⟩ (Radiopharmaceuticals for Positron Emission Tomography—Compounding) and EU Good Manufacturing Practice for Active Substances Part II, Annex 3. The terminal product is a sterile, apyrogenic solution of the 18F-pyrrole tracer intended for intravenous bolus injection in rodent and non-human primate brain imaging studies targeting the serotonin 5-HT₆ receptor, where the Boc-pyrrole moiety provides the key metabolic latency required for adequate brain uptake. |
Competitive 2-Borono-1H-Pyrrole-1-Carboxylic Acid 1-(1,1-Dimethylethyl) Ester prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615651039172
Email: sales9@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
| Parameter | Method/Instrument | Acceptance Criterion |
|---|---|---|
| Assay (anhydrous, boronic acid equivalent) | HPLC-UV (254 nm), C18 column, acetonitrile/0.1% H3PO4 gradient | ≥ 98.0% area |
| Boroxine content | 1H NMR (400 MHz, DMSO-d6) | ≤ 2.0% molar |
| Water (Karl Fischer) | Metrohm 901 Titrando, coulometric | ≤ 0.5% w/w |
| Residual Pd | ICP-MS (Agilent 7900) | ≤ 20 ppm |
| Melting range | USP 〈741〉, capillary | 87–91 °C |
| Chloride content | Ion chromatography, Metrohm 930 Compact IC Flex | ≤ 250 ppm |